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Figure S1. Gene expression after i.m. administration of pGFP in mouse GA. (a) BALB/c mice were administered 
50 μg pGFP in 50 μl 0.9% saline or 50 μl saline alone in the GA. 2, 4 and 8 days after injection GA were dissected and 
real-time RT-qPCR was performed to determine changes in gene expression of (b) OKSM reprogramming factors, (c) 
endogenous pluripotency markers, (d) myogenesis-related genes and (e) GFP transgene. GFP mRNA was normalised to 
the values form day 2. Expression levels of other mRNAs were normalised to saline-injected controls. No statistically 
significant differences in gene expression were detected between groups, assessed by one-way ANOVA, n=3, n.a. 
indicates no amplification of the target. 
 
 
 
  
Figure S2. Characterisation of pOKSM and pGFP injected GA tissues. (a) BALB/c mice were administered 50 μg 
pOKSM or pGFP in 50 μl 0.9% saline, or 50 μl saline alone, in the GA. 2, 4 and 8 days p.i., muscles were dissected for 
gene expression and histological analysis. (b) Representative images of GFP+ muscle fibers located in pOKSM and 
pGFP injected muscles, scale bar represents 50 μm. *p<0.05 indicates statistically significant differences in the number 
of GFP+ fibers compared to saline-injected controls, assessed by one-way ANOVA and Tukey test, (n=2 GA, 3 (whole) 
sections/muscle). (c) Representative images of the needle tract left by i.m. injection in pGFP and saline-injected 
controls. Left panel shows H/E staining and right images show green fluorescence, scale bar represents 100 μm. (d) 
Cd11b expression was assessed by real-time RT-qPCR in pOKSM, pGFP and saline-injected muscles. No statistically 
significant differences were found among groups, assessed by one-way ANOVA, n=4. (e) IHC of a cluster containing 
reprogrammed cells, 2 days after pOKSM administration. Left and middle images show maximum intensity projections 
of Z stacks (DAPI/GFP/Cd11b/NANOG and DAPI/Cd11b/NANOG staining, respectively). White arrowhead points at a 
Cd11b+NANOG- cell. The right panel offers an orthogonal view of a specific section, DAPI/Cd11b/NANOG IHC. 
Images were taken with a confocal microscopy at 100X magnification, scale bar represents 50 μm. 
  
Figure S3. Characterisation of NANOG
+
/GFP
+
 cells clusters in pOKSM injected muscles. (a) BALB/c mice were 
administered 50 μg pOKSM in 50 μl 0.9% saline in the GA, dissected 2 days p.i. for histological analysis. (b) 
Representative images of NANOG
+
/GFP
+ 
cell clusters obtained by confocal microscopy. Left panels show maximum 
projection intensity of the Z-stack while right panels offer the orthogonal view of a specific section. Axes in right panels 
cross at NANOG+GFP+ double positive cells, which are tagged by white arrowheads in the left images. Scale bar 
represents 50 μm. 
  
Figure S4. Characterisation of in vivo reprogrammed cell clusters in Nanog-GFP mice GA. (a) Nanog-GFP mice 
were administered 50 μg pOKS and 50 μg pM in 50 μl 0.9% saline, or 50 μl saline alone, in the GA. Muscles were 
dissected 2 days p.i. for histological analysis. (b) Counting of GFP+/NANOG+, GFP+/OCT4+, GFP+/AP+ and 
GFP+/SSEA1+ cell clusters in reprogramed and saline-injected tissues, n=1. 
 
 
 
 
 
 
  
Figure S5. IHC in Nanog-GFP and Pax3-GFP mice GA tissue sections. (a)  Nanog-GFP and Pax3-GFP mice were 
i.m. administered 50 μg pOKS and 50 μg pM in 50 μl 0.9% saline, or 50 μl saline alone, in the GA. Muscles were 
dissected 2 days p.i. for histological analysis. (b) Absence of GFP+ cell clusters in tissue sections from saline-injected 
Nanog-GFP and Pax3-GFP mice (100X, scale bars represent 50 μm). Brightfield and fluorescence images show the 
same region within the tissue. (c) IHC for the expression of PAX7, a marker of satellite cells, and PDGFrβ, a marker of 
pericytes, in Nanog-GFP mice administered with reprogramming pDNA (100X, scale bar represents 50 μm). (d) IHC 
for the expression of pluripotency, satellite cell and pericyte markers in Nanog-GFP mice administered with saline 
solution (100X, scale bar represents 50 μm). (d) IHC for the expression of the pluripotency marker NANOG in saline-
injected Pax3-GFP mice (100X, scale bar represents 50 μm). 
  
Figure S6. Effects of in vivo reprogramming towards pluripotency in healthy skeletal muscle. (a) BALB/c mice 
were administered 50 µg pOKSM in 50 μl 0.9% saline, or 50 μl saline alone, in the GA. Muscles were dissected 2, 4, 8, 
12, 50 and 120 days after injection for histological analysis. (b) H&E staining focusing on the evolution of clusters of 
mononucleated cells (40X magnification, scale bar represents 100 μm). (c) TUNNEL staining to detect apoptotic nuclei, 
stained in brown (40X, scale bar represents 100 μm). 
 
 
  
Figure S7. Effects of in vivo reprogramming towards pluripotency after transection of the medial head of the GA. 
(a) Diagram of the anatomical localisation where the injury was created in the medial head of the GA: coronal (left) and 
sagittal plane (right). The incision was performed mid-length in the medial head of the GA and covered the 100% of its 
width and depth. (b) Nanog gene expression upon i.m. administration of 100 μg pOKSM at the time of injury or 5 or 7 
days after surgery. Relative gene expression was normalised to saline-injected controls. *p<0.05 indicates statistically 
significant differences in the expression of Nanog when the reprogramming pDNA was administered at the time of 
injury or one week later, assessed by one-way ANOVA and Tukey’s test. Data are presented as 2-∆∆Ct ± propagation of 
error, n=3. 
  
Figure S8. Functional assessment of muscle regeneration. (a) The medial head of the GA of BALB/c mice was 
surgically lacerated and 100 μg pOKSM in 40 μl 0.9% saline or 40 μl saline alone were i.m. administered 7 days after 
injury. Functional recovery was assessed 9 and 14 days after surgery. (b) In vivo myography setup. The GA was 
exposed, an electrode was placed on the sciatic nerve for direct stimulation while the Achilles tendon was tied to a force 
transducer. (c) Twitch contraction was produced by a single stimulation (red arrow) at the optimal current (L= latent 
period, C= contraction, R=relaxation). (d) Tetanus contraction was produced by repeated stimulations (red arrows) with 
a 150 Hz frequency that did not allow the relaxation of the muscle between single contractions. Muscle forces under (e) 
twitch and (f) tetanus contractions were recorded on days 9 and 14 after injury and expressed as a % of the force 
produced by the contralateral (intact) hind limb. Data are presented as mean ± SE, n=4. No statistically significant 
differences were found between groups. 
 
 Supplementary tables 
Table S1. Primer sequences used in the study. 
 
 
 
 
 Table S2. Percentage of centronucleated myofibers after transection and administration of reprogramming 
factors or saline control.  
 
Group day 9 day 14 
Injury d0 saline d7 33.9 ± 12.9 45.6 ± 6 
Injury d0 OKSM d7 56.0 ± 23.4 18.2 ± 7.7 
Data are expressed as Mean ± SD. 
 
Table S3. Percentage of fibrotic area after transection and administration of reprogramming factors or saline 
control.  
Group day 9 day 14 
Injury d0 saline d7 15.4 ± 5.2 22.6 ± 6.7 
Injury d0 OKSM d7 12.3 ± 5.1 15.5 ± 6.5 
Fibrotic area is calculated as the percentage of the muscle cross-section that stained positively for collagen. Data are 
expressed as Mean ± SD. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Supplementary Methods 
TUNEL staining. 10 µm thick frozen tissue sections were processed with DeadEnd Colorimetric TUNEL Assay kit 
(Promega, G7130, UK) according to manufacturer’s specifications. In brief, tissue sections were fixed in 4% 
paraformaldehyde (15 min, RT) and permeabilised with Proteinase K (20µg/ml, 15 min, 37°C). Sections were then 
incubated with TUNEL reaction mixture containing recombinant terminal deoxynucleotidyl transferase (rTdT) and 
biotynilated nucleotide for 1 h at 37°C. After several washes in 2X SSC and PBS, slides were blocked with 0.3% hydrogen 
peroxide in PBS (5 min) and incubated with horseradish peroxidise-labelled streptavidin (Streptavidin-HRP) antibody 
diluted 1:500 in PBS. Reaction with diaminobenzidine (DAB) was observed by light microscopy (Leica, UK) and 
representative images were taken at 40X magnification. 
 
Optimisation of the timing of in vivo reprogramming towards pluripotency after physically-induced skeletal muscle 
injury. Transection of the medial head of the GA was performed as described before and 100 μg pOKSM or 40 μl saline 
solution were administered at the time of injury, 5 or 7 days after transection. GA muscles were dissected 2 days after 
injection and gene expression was investigated by real-time RT-qPCR as previously described. 
 
Electromechanical evaluation of muscle force. Functional recovery of the GA after injury was measured by recording 
the force produced under fast twitch and tetanus contraction, via direct stimulation of the sciatic nerve. Such measurements 
were taken with an Aurora 1300A myograph (Aurora Scientific Inc, Canada) that allowed in vivo recordings. In brief, 
mice were anesthetised with isoflurane and the GA was exposed and released from the fascia as previously described. The 
GA and sciatic nerve were blunt dissected. The femur’s head has prepared free from surrounded tissue and fixed to the 
platform clamp as shown in Figure 7b preventing movement of the leg upon the stimulation.  The Achilles tendon was 
connected to the force transducer and an electrode was placed on the sciatic nerve. The nerve and muscle were kept moist 
with paraffin oil at 37°C throughout the measurements. Since we aimed to record isometric contractions, the optimal 
muscle length was first determined by repeating the twitch measurements with a fixed current of 5V and while adjusting 
the length of the muscle. The maximum twitch force was then assessed by increasing the voltage of stimulation.  Finally, 
tetanus contractions were produced by repeated stimulation at the optimal length and current identified from the twitch 
measurements, with a 150 Hz frequency. 1 and 5 minutes were allowed between twitch and tetany measurements, 
respectively, to avoid muscle fatigue that could influence the results. We calculated the percentage of recovered force as 
the ratio between the force produced by the left (injured) and right (intact) GA, n=4. 
